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Background. There are different metabolic syndrome traits among patients with different ethnicities. Methods. We investigated
this by studying 44 South Asians and 54 Europeans and classified them in three groups according to the occurrence of metabolic
syndrome (MetS) and Type 2 Diabetes (T2D). Insulin sensitivity index (ISI), static, dynamic, and total beta-cell responsivity indices
(Φ), and disposition indices (DIs) were calculated with the use of oral minimal model (OMM). Results. In both ethnicities, ISI was
lower in the subgroup with MetS and T2D as compared to the subgroup without MetS nor T2D (𝑃 < 0.004). South Asians without
MetS were more insulin resistant than Europeans without MetS (𝑃 = 0.033). In the South Asians, ISI, dynamic DI, and static DI
were associated significantly (𝑃 < 0.006) with high-density lipoprotein cholesterol and triglycerides. In the Europeans, ISI was
associated with waist-to-hip ratio (𝑃 = 0.005) and systolic and diastolic blood pressure (𝑃 < 0.005), while static DI was related
to the systolic blood pressure (𝑃 = 0.005). Conclusions. MetS was linked with insulin resistance and reduced capacity to handle
glucose regardless of ethnicity. ISI and DIs were associated with lipid traits in South Asians and with blood pressure in Europeans
suggesting that insulin resistance enhances different metabolic syndrome traits among different ethnicities.
1. Introduction
Overweight and physical inactivity enhance each other and
decline the sensitivity to insulin. Resistance to insulin is char-
acteristic of metabolic syndrome (MetS), which is defined
as a cluster of the following cardiovascular risk factors:
central obesity, impaired glucose tolerance, dyslipidemia, and
hypertension. MetS constitutes a major health problem, as it
is strongly associated with type 2 diabetes mellitus (T2D) and
cardiovascular disease [1–3]. Furthermore, insulin resistance
is a consistent finding in T2D and appears to contribute to
the development of T2D. However, T2D develops only if
there is dysfunction of beta-cells [4]. In the absence of beta-
cell dysfunction individuals can compensate indefinitely for
resistance to insulin action with the appropriate hyperinsu-
linemia. Therefore, many people with remarkable resistance
to insulin may never develop T2D [5, 6].
Lifestyle factors clearly underlie MetS incidence, but
genetic susceptibility may be important as well [7]. For
example, specific ethnic groups are more susceptible to MetS
than others [8, 9]. In particular, South Asians are predisposed
to develop MetS and subsequently T2D and cardiovascular
disease at a younger age [10–12]. They also have a higher
prevalence of abdominal obesity, are less sensitive to insulin,
and have a lower glucose disposal rate than Europeans [12–
14]. In addition, South Asians have lower plasma levels of
HDL and adiponectin and higher levels of glucose, insulin,
leptin, complement C3, plasminogen activator inhibitor-1,
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fibrinogen, and tissue plasminogen activator compared to
Europeans [15–20]. However, traditional risk factors such
as smoking, hypertension, and dyslipidemia do not explain
the increased risk for cardiovascular disease in South Asians
[21, 22]. Insulin resistance itself has been held responsible for
the high rates of T2D and cardiovascular disease in this ethnic
group [10, 12].
Oral minimal modeling is a pharmacokinetic/pharmaco-
dynamic algorithm developed to estimate beta-cell function
and insulin sensitivity index (ISI) from dynamic data [23]. In
the present study, we used this oral minimal model (OMM)
to investigate the relationship between MetS traits and beta-
cell function in South Asian and European families with
prevalent T2D.
2. Materials and Methods
2.1. Subjects. The recruitment of patients with T2D and their
relatives at our university outpatient clinic has been described
in detail previously [24]. In brief, 48 South Asians and 54
Europeans that are residing in the Netherlands were initially
recruited for the present study and we used an oral glucose
tolerance test (OGTT) to group the subjects in T2Dor noT2D
according to theWHO criteria. In addition, the International
Diabetes Federation (IDF) criteria were used to define MetS
[25]. Four South Asians had T2D but not MetS and were
excluded from the study as the number of subjects was
too small for meaningful analyses and there were no Euro-
pean counterparts for comparison. Hence, 98 subjects were
included in our analyses (44 South Asians and 54 Europeans)
from 25 families (25 patients with T2D but not on insulin
therapy and 73 relatives) and they were distributed among 3
groups; no metabolic syndrome/no type 2 diabetes mellitus
(noMetS/noT2D), metabolic syndrome/no type 2 diabetes
mellitus (MetS/noT2D), and metabolic syndrome/type 2
diabetes mellitus (MetS/T2D).
Written informed consent was obtained from all partic-
ipants. The Erasmus Medical Ethics Review Board approved
the study protocol.
2.2. Physical Examination. Body height and weight were
measured in light clothing without shoes and were used to
estimate body mass index. Waist circumference was mea-
sured halfway between the lowest rib and the iliac crest while
the maximum circumference of the hips was measured in
the standing position; from thesemeasurements the waist-to-
hip ratio was calculated. Systolic and diastolic blood pressure
weremeasured in the sitting positionwith an electronic blood
pressure monitor (Datascope Accutorr Plus Inc., Montvale,
NJ), after five minutes’ rest.
2.3. Samples and Measurements. All participants underwent
a 210min OGTT. A 75 g glucose load was administered (𝑡 =
0), after an overnight fast, and 11 venous blood samples were
acquired at prespecified time intervals (−60min, −15min,
15min, 30min, 45min, 60min, 90min, 120min, 150min,
180min, and 210min) for the measurement of plasma glu-
cose, insulin, and C-peptide levels. Baseline blood samples
were obtained in order to estimate glucose, insulin, C-peptide
plasma concentrations, and the lipid profile.
Plasma glucose was estimated using a hexokinase-based
method (Gluco-quant; Roche Diagnostics, Mannheim, Ger-
many). Plasma insulin and C-peptide were measured sep-
arately by a competitive chemiluminescent immunoassay,
supplied by Euro/DPC. The assay was performed on a
DPC Immulite 2000 analyzer (Euro/DPC) according to the
manufacturer’s recommended protocol. Serum total choles-
terol, HDL, LDL, and triglycerides were determined with
an automatic enzymatic procedure by Roche Diagnostics
(Mannheim, Germany).
2.4. Oral Minimal Model Calculations. The OMM, which
consists of the glucose OMM and the C-peptide OMM, was
used to describe changes of plasma glucose, insulin, and
C-peptide concentrations during an oral glucose stimulus
[26–28]. Glucose, C-peptide, and insulin concentrationswere
measured at 11 time points before and after intake of 75 g
glucose.The glucoseOMMestimated ISI with plasma glucose
and insulin concentrations measured during the OGTT. In
addition the C-peptide OMM indices were calculated during
the oral glucose tolerance test and in terms of insulin secre-
tion can be interpreted as follows: (1) the basal (Φbasal) that
gives a basal nonstimulated measurement of insulin secre-
tion, (2) the dynamic (Φdynamic) that provides the amount
of insulin secreted during the dynamic phase (first-phase
secretion by beta-cells), (3) the static (Φstatic) that assesses the
release of insulin that occurs after a time delay (second-phase
secretion by beta-cells) and represents a beta-cell response
according to the prevailing glucose concentration, and (4)
the total (Φtotal) overall secretion which is the sum of the
dynamic and static phase release of insulin from beta-cells.
The parameters of glucose OMM and C-peptide OMM were
multiplied to obtain the disposition indices (DIs), which
is a measure for beta-cell function corrected for insulin
sensitivity. It can be considered ameasure of the functionality
of the pancreas in the intact individual: DIbasal = Φbasal × ISI,
DIdynamic = Φdynamic × ISI, DIstatic = Φstatic × ISI, and DItotal =
Φtotal×ISI.We performed the analyses with SAAMII software
[29].
2.5. Statistical Analysis. Continuous variables are expressed
as mean ± SEM, unless indicated otherwise. ANOVA test
was used to compare the mean of raw data presented in
Table 1 and the figures of different subgroups within the two
ethnicities. Adjusted analyses were performed with multiple
linear regressionmodels inwhich all covariables were entered
synchronously.
A 𝑃 < 0.05 was considered statistically significant. All
statistical tests were conducted with SPSS software, version
20 (SPSS Inc., Chicago, IL).
3. Results
3.1. Baseline Characteristics. 32 out of 44 South Asians
(72.7%, 95% CI 58.0 to 83.8%) and 23 out of 54 Europeans
(42.6%, 95% CI 30.3 to 55.9%) had MetS according to the
IDF criteria. In Table 1, the general characteristics of the
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Table 1: General characteristics of the study subjects.
South Asians (𝑛 = 44) Europeans (𝑛 = 54)
noMetS/noT2D MetS/noT2D MetS/T2D noMetS/noT2D MetS/noT2D MetS/T2D
𝑁 12 14 18 31 12 11
Male/female 6/6 9/5 10/8 9/22 5/7 6/5
Age (yrs) 33.9 ± 8.0 48.2 ± 10.1‡ 51.4 ± 10.4‡ 39.6 ± 10.2 40.3 ± 10.2 61.8 ± 8.7∗†
Height (m) 1.67 ± 0.12 1.68 ± 0.12 1.63 ± 0.08 1.75 ± 0.10 1.78 ± 0.08 1.77 ± 0.07
Weight (kg) 74.1 ± 16.3 78.8 ± 9.6 76.3 ± 12.4 77.8 ± 12.2 103.5 ± 28.7∗ 98.3 ± 11.8∗
Body mass index (kg/m2) 26.3 ± 3.3 28 ± 2.7 28.7 ± 4.1 25.4 ± 3.1 32.6 ± 8.2∗ 31.4 ± 4.3∗
Waist (cm) 93 ± 12 98 ± 9 97 ± 7 88 ± 12 110 ± 19∗ 110 ± 13∗
Hip (cm) 105 ± 7 104 ± 4 103 ± 8 106 ± 8 120 ± 16∗ 116 ± 8
Waist-to-hip ratio 0.89 ± 0.08 0.94 ± 0.07 0.95 ± 0.08 0.83 ± 0.09 0.92 ± 0.08∗ 0.94 ± 0.07∗
Systolic blood pressure (mmHg) 114 ± 11 130 ± 16 136 ± 15‡ 120 ± 12 137 ± 14∗ 137 ± 14∗
Diastolic blood pressure (mmHg) 76 ± 9 83 ± 12 82 ± 9 74 ± 8 84 ± 9∗ 84 ± 11∗
Total cholesterol (mmol/L) 4.7 ± 0.7 5 ± 0.9 4.6 ± 1.2 4.8 ± 1 4.9 ± 0.9 4.5 ± 1.1
Triglycerides (mmol/L) 0.97 ± 0.37 1.43 ± 0.65 1.55 ± 0.65 0.97 ± 0.36 1.39 ± 0.77 1.38 ± 0.55
HDL (mmol/L) 1.19 ± 0.37 1.01 ± 0.21 1.05 ± 0.22 1.47 ± 0.40 1.11 ± 0.19∗ 1.17 ± 0.26
LDL (mmol/L) 3.02 ± 0.63 3.30 ± 0.76 2.80 ± 1.08 2.77 ± 0.93 3.01 ± 0.80 2.55 ± 0.90
Ratio HDL-cholesterol 4.2 ± 1.3 5.2 ± 1.4 4.4 ± 1.2 3.5 ± 1.1 4.5 ± 1.2∗ 3.9 ± 0.9
Fasting plasma glucose (mmol/L) 5.3 ± 0.3 5.8 ± 0.5 7.4 ± 1.5§‡ 5.3 ± 0.5 5.7 ± 0.5 8.1 ± 1.1∗†
OGTT (mmol/L) 5.5 ± 1.7 6.8 ± 1.2 13.8 ± 5.2§‡ 5.7 ± 1.5 6.7 ± 1.8 13.9 ± 2.8∗†
Insulin (pmol/L) 53.5 ± 46.8 73.8 ± 49.2 58.3 ± 38.4 35.8 ± 29 73.7 ± 35.6 78.5 ± 72.2
HDL: high-density lipoprotein; LDL: low-density lipoprotein; OGTT: oral glucose tolerance test (2 hours); MetS: metabolic syndrome; T2D: type 2 diabetes
mellitus.
∗ indicates statistically significant differences between the noMetS/noT2D and the other 2 subgroups within Europeans; † indicates statistically significant
differences between the MetS/noT2D and the Met/T2D subgroup within Europeans; ‡ indicates statistically significant differences between noMetS/noT2D
and the other 2 subgroups within South Asians; § indicates statistically significant differences between MetS/noT2D and the Met/T2D subgroup within South
Asians.
3 subgroups are shown according to ethnicity. The systolic
blood pressure, fasting, and 2 h plasma glucose levels were
increased in South Asians with MetS and T2D compared
to the noMetS/noT2D group. South Asians with MetS and
T2Dwere on average 10.4 years younger than Europeans with
MetS and T2D. Compared to the analyses of the South Asian
subgroups, we observed a larger heterogeneity among the
3 subgroups of the Europeans in clinical and biochemical
characteristics with significant differences in age, weight,
body mass index, waist, waist-to-hip ratio, blood pressure,
and fasting and 2 h plasma glucose levels.
3.2. Insulin Sensitivity. The ISIs of the three subgroups
according to ethnicity are shown in Figure 1. Subjects without
MetS had higher ISI than those with MetS. On average
and adjusted for sex and age, the Europeans had 7.18 ×
10−4 dL/kg/min per 𝜇U/mL (95% CI 0.58 to 13.78, 𝑃 = 0.033)
higher ISI than the South Asians. This was fully explained
by the differences between the two subgroups without MetS
(after excluding this subgroup to the analysis the effect of
ethnicity disappeared, 𝑃 = 0.367).
3.3. Beta-Cell Responsivity Indices. The fitting of both C-pep-
tide and glucoseOMMwas satisfactory as the averageweight-
ed residuals did not deviate systematically from the zero value
(Supplementary Figures 1 and 2 in Supplementary Material
available online at http://dx.doi.org/10.1155/2016/9286303).
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Figure 1: Insulin sensitivity index (ISI) assessed by the OMM in
South Asian (SA) and European (EUR) subgroups. ∗ indicates a
statistically significant difference between noMetS/noT2Dand other
subgroups.
Figure 2 shows the beta-cell responsivity indices esti-
mated by the C-peptide OMM during the OGTT. Adjusted
for sex and age, ethnicity was significantly related to the basal
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Figure 2: 𝛽-cell insulin responsivity indices in South Asian (SA) and European (EUR) subgroups. ∗ indicates a statistically significant
difference in comparison with the noMetS/noT2D subgroup; ∗∗ indicates a statistically significant difference between the MetS/noT2D and
MetS/T2D subgroup.
responsivity index,𝛽= 0.086× 10−9/min, 95%CI 0.17 to 0.155,
and 𝑃 = 0.016, but not to the other responsivity indices,
𝑃 > 0.7. Within the South Asian group adjusted for sex and
age, the MetS/noT2D group had 0.164 × 10−9/min (95% CI
0.045 to 0.282, 𝑃 = 0.008) higher basal responsivity index
compared to the other subgroups. The basal responsivity
index was not significantly different between the European
subgroups.The dynamic, the static, and the total responsivity
indices showed all the same trend of a lower beta-cell
response (in effect less insulin secretion) in the MetS/T2D
groups in both ethnicities: −191.9 × 10−9 (95% CI −282.2 to
−101.6, 𝑃 = 0.001), −12.1 × 10−9/min (95% CI −16.1 to −8.0,
𝑃 = 0.001), and −14.3 × 10−9/min (95% CI −18.9 to −9.6, 𝑃 =
0.001), respectively. The South Asian noMetS/noT2D and
MetS/noT2D had similar values in the dynamic, the static,
and the total responsivity indices, whereas in the Europeans
there was a clear trend to gradually lower values over these
groups in the direction of the MetS/T2D subgroup: 𝑃for trend
= 0.005, 0.001, and 0.001, respectively.
3.4. Disposition Indices. The DIs according to subgroup and
ethnicity are shown in Figure 3. Adjusted for sex and age the
four DIs did not differ significantly between the ethnicities
(𝑃 > 0.11). Both ethnicities showed the same gradual
course of the different DI from high to intermediate and
low over the noMetS/noT2D, MetS/noT2D, and MetS/T2D
subgroups, respectively (𝑃for trend < 0.002). There were
no clear differences between the ethnicities, although the
European noMetS/noT2D subgroup had relatively high DI
compared to the same South Asian subgroup.
3.5.MetS Traits andOMMIndices. Therelationships between
the MetS traits and OMM indices adjusted for sex and age
according to ethnicity are shown in Table 2. The MetS traits
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Figure 3: Disposition indices in South Asian (SA) and European (EUR) subgroups. ∗ indicates a statistically significant difference in
comparison with the noMetS/noT2D subgroup.
were not used in a large “holistic” multiple linear regression
model since they are correlated. Therefore, each trait was
analyzed separately in a multiple linear regression model
adjusted for sex and age. Waist-to-hip-ratio was strongly
associated with ISI in both ethnicities, but it may have a more
detrimental effect of the glucose disposition in Europeans
than in the South Asians. The dyslipidemia characterized by
high triglycerides and low HDL was related to ISI and the
DIs solely in the South Asians, whereas blood pressure, both
systolic and diastolic, was solely related to ISI and the DIs in
the Europeans. As expected, fasting glucose was associated
with ISI and DIs as these indices are calculated with glucose
values.
4. Discussion
In the present study, we found a clear trend for increasing
insulin resistance from noMetS/noT2D to MetS/noT2D and
to MetS/T2D.We also found that South Asians without MetS
were more resistant to insulin than a corresponding group
of Europeans. In the European families, the dynamic, static,
and total beta-cell responsivity indices followed the trend of
ISI in the same direction over the three subgroups towards
decreasing insulin secretion by the beta-cells in the T2D
group. The South Asian noMetS/noT2D and MetS/noT2D
subgroups both had high beta-cell responsivity indices and
the MetS/T2D subgroup had low values. The DIs are the
product of ISI and beta-cell responsivity indices and inde-
pendent of ethnicity followed a decreasing trend over the
subgroups in the direction of T2D. Notably, a number of
separate MetS traits had different associations in the two
ethnicities: dyslipidemia had a strong relationship with ISI
and DI in the South Asians, whereas blood pressure was
associated with ISI and DI in the Europeans.
Over the last years several studies have examined the
effect of lifestyle, dietary habits, and genetic polymorphisms
on the development of MetS in different ethnicities, in order
to identify high-risk populations such as the South Asians,
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Table 2: Relationship betweenmetabolic syndrome traits and insulin sensitivity index (ISI), dynamic disposition index (DIdynamic), and static
disposition index (DIstatic) adjusted for sex and age according to ethnicity.
Metabolic syndrome trait ISI 95% CI 𝑃 DIdynamic 95% CI 𝑃 DIstatic 95% CI 𝑃
×10−4 dL/kg/min per 𝜇U/mL ×10−10 dL/kg/min per 𝜇U/mL ×10−10 dL/kg/min per 𝜇U/mL
South Asians
Waist-to-hip ratio −61 −109 to −13 0.015 −9.4 −27.0 to 8.1 0.284 −0.7 −1.8 to 0.3 0.181
Triglycerides (mmol/L) −7.1 −11.9 to −2.3 0.005 −2.0 −3.7 to −0.3 0.022 −0.1 −0.2 to −0.04 0.007
HDL (mmol/L) 25.7 15.8 to 35.7 0.001 5.9 1.9 to 9.9 0.005 0.5 0.2 to 0.7 0.001
Systolic blood pressure (mmHg) −0.2 −0.4 to −0.03 0.028 0.06 −0.1 to 0.02 0.129 −0.005 −0.009 to −0.0006 0.026
Diastolic blood pressure (mmHg) −0.2 −0.5 to 0.1 0.169 −0.04 −0.1 to 0.07 0.487 −0.003 −0.01 to 0.003 0.281
Fasting plasma glucose (mmol/L) −3.0 −5.3 to −0.6 0.014 −1.2 −2.0 to −0.4 0.003 −0.07 −0.1 to −0.003 0.002
Europeans
Waist-to-hip ratio −95 −159 to −31 0.005 −25.6 −49.6 to −1.7 0.036 −22.9 −4.8 to −0.2 0.075
Triglycerides (mmol/L) −7.9 −18 to 2.4 0.131 −0.3 −4.0 to 3.5 0.888 −0.1 −0.5 to 0.3 0.518
HDL (mmol/L) 10.6 −5.9 to 27.1 0.204 1.3 −4.7 to 7.3 0.668 0.3 −0.3 to 1.0 0.266
Systolic blood pressure (mmHg) −0.6 −0.9 to −0.3 0.001 −0.1 −0.3 to −0.02 0.026 −0.02 −0.03 to −0.006 0.005
Diastolic blood pressure (mmHg) −0.8 −1.3 to −0.3 0.004 −0.1 −0.3 to 0.05 0.144 −0.02 −0.04 to 0.004 0.111
Fasting plasma glucose (mmol/L) −5.2 −10.3 to −0.09 0.046 −2.3 −4.1 to −0.5 0.01 −0.2 −0.4 to 0.005 0.056
HDL: high-density lipoprotein; ISI: insulin sensitivity index; DIdynamic: dynamic disposition index; DIstatic: static disposition index.
who appear to have an increased predisposition for T2D
[30–32]. Most of these reports focused on epidemiological
analyses and evaluations of the impact of biochemical and
physical characteristics (e.g., total abdominal fat and intra-
abdominal adipose tissue) on the development of MetS.
In a number of studies, ISI and beta-cell function were
assessed in different ethnicities using fasting blood glucose
and plasma insulin concentrations (for instance, homeostatic
model assessment (HOMA)) [33–35]. These methods do not
assess the dynamic response of beta-cells to glucose stimuli
[36, 37]. Our study is the first to employ OMM in order
to examine the relationships between MetS traits and ISI
and beta-cell response. The estimations of ISI and insulin
secretion by OMM are reasonably well correlated with those
assessed by the hyperinsulinemic euglycemic clamp method
[38].
We demonstrated for the first time, to our knowledge,
that in South Asians and Europeans both ISI and beta-
cell function are lower in subjects with MetS and in sub-
jects with MetS and T2D compared to noMetS/noT2D
subjects. In addition, we confirmed an increased insulin
resistance in noMetS/noT2D South Asians compared to
noMetS/noT2D Europeans [39, 40]. Moreover, in South
Asians with noMetS/noT2D the disposition indices were
lower comparing to the disposition indices in Europeans and
not statistically different from the disposition indices in South
Asians with MetS/noT2D.These findings indicate that South
Asians are a vulnerable population and have an increased risk
to develop chronic diseases such as MetS and T2D, in which
insulin resistance and beta-cell function are key pathogenetic
factors.
Our study showed that OMM could be used to evaluate
glucose homeostasis in different populations and to examine
associations between insulin resistance, abnormal beta-cell
function, and MetS traits. Waist-to-hip ratio reflects the
association between visceral obesity and the causal path
from insulin resistance to T2D [41–43].Hypertriglyceridemia
and increased enzymes involved in triglyceride transport
and metabolism may have a toxic effect on beta-cells [44],
but hypertriglyceridemia can be a consequence of insulin
resistance and T2D as well. Remarkably, triglycerides and
HDL were associated with ISI and DIs in South Asians.
Unfortunately, we cannot infer fromour datawhether dyslipi-
demia was the cause or the consequence of insulin resistance
and reduced DIs. In the European families, insulin resistance
and reduced DI were associated with raised blood pressure.
This suggests that disorders of carbohydratemetabolismwere
complicated by higher levels of blood pressure. A possible
explanation is an impaired insulin signaling through PI3K
signaling pathway and the increased vascular inflammation
noted in insulin resistance which can decrease nitric oxide
(NO) production and increase Endothelin-1 (ET-1) secretion
leading to raised blood pressure [45, 46]. The differences in
the associations between metabolic syndrome traits, beta-
cell function, and insulin sensitivity in different ethnicities
have not been fully explained yet. A possible etiology is
the different genetic profile of Europeans and South Asians;
however, further research is required towards this direction
in order to understand the metabolic pathways and the effect
of the genome on these associations.
In the present analysis, we investigated associations
between metabolic syndrome traits and insulin sensitivity
and beta-cell function after adjusting for age and sex. Of note
the results did not change significantly when we adjusted
also for BMI. The only differences that we noticed were in
Europeans where there was no longer an association between
ISI, waist-to-hip ratio, and diastolic blood pressure as well
as a correlation between fasting glucose and ISI and DIstatic
(Supplementary file Table 1).
4.1. Strengths and Limitations. We have recruited subjects
through families with prevalent T2D. Family studies avoid a
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number of serious selection biases, but the findings cannot
easily be generalized to the general population. Moreover,
we prefer to analyze family data using a family matrix, for
instance, SOLAR, but unfortunately there were too many
small cells. Adjustment for family ties in regression analyses
suffered from the same problem; therefore, we restricted the
adjustment of all primary analyses to age, which correlates
with generation in kindreds. We did not analyze genetic
variation, and transmission was not a topic of our research.
Moreover, separate analyses of small and large families did
not change the results (data not shown).
We chose the comparison between the MetS/T2D status
groups and not between the two ethnic groups because South
Asians and Europeans differ in many aspects and therefore
we tried to avoid bias due to the ethnicity differences.
We have used the IDF criteria for MetS, because they
take ethnic specific cut-off points for central obesity, in effect
waist circumference, into account. South Asians residing in
the Western world differ in lifestyle and phenotype from
the South Asians living in South Asia, and therefore we
tested the necessity of such ethnicity-specific cut-off points:
if the European cut-off points were used for all subjects, only
three male South Asians would have not been classified as
MetS. Still a number of arguments could be made to include
analyses using a single cut-off point, but the effects on our
results were negligible (data not shown) and therefore we
decided to follow the IDF recommendations.
A limitation of the study was the relatively small sample
size and for this reason these findings cannot be generalized
to the broader community. Furthermore, we excluded the
noMetS/T2D subgroup, because meaningful analysis was not
possible, as there were only 4 South Asians and no Europeans
counterparts.
5. Conclusions
In our study, we observed low ISIs in the MetS/T2D
group relative to the noMetS/noT2D group in both eth-
nicities, a finding that indicates an association between
insulin resistance and a pathologic metabolic state (T2D).
The pathogenic mechanisms that lead to insulin resistance
appear to differ among ethnicities, as ISI and DIs were
associated with different metabolic traits in each ethnicity.
The simultaneous assessment of insulin sensitivity and beta-
cell function allowed us to study metabolic profiles that
promote T2D and glucose intolerance.We used this primarily
to explore the underlying mechanisms of disturbances in
glucose metabolism, but also to explore the potential of
designing ethnicity-specific risk models for early identifi-
cation of subjects that are at risk for developing diabetes
mellitus. In this study, SouthAsians, in contrast to Europeans,
appear to be predisposed to insulin resistance and exhibit
impaired beta-cell function at an earlier age. Dyslipidemia
related to insulin resistance and pancreatic dysfunction may
underlie or enhance this susceptibility of South Asians.
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